These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28975985)
21. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
22. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells. Shi K; Ru Q; Zhang C; Huang J Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391 [TBL] [Abstract][Full Text] [Related]
23. Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway. Wang J; Yang T; Chen H; Li H; Zheng S Biochem Biophys Res Commun; 2018 Apr; 498(3):424-430. PubMed ID: 29477843 [TBL] [Abstract][Full Text] [Related]
24. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. He J; Zuo Q; Hu B; Jin H; Wang C; Cheng Z; Deng X; Yang C; Ruan H; Yu C; Zhao F; Yao M; Fang J; Gu J; Zhou J; Fan J; Qin W; Yang XR; Wang H Cancer Lett; 2019 May; 450():98-109. PubMed ID: 30790682 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma. Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968 [TBL] [Abstract][Full Text] [Related]
26. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway. Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236 [TBL] [Abstract][Full Text] [Related]
27. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
28. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
30. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920 [TBL] [Abstract][Full Text] [Related]
32. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. Huang WC; Tung SL; Chen YL; Chen PM; Chu PY BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298 [TBL] [Abstract][Full Text] [Related]
33. Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells. Wu Y; Lin X; Di X; Chen Y; Zhao H; Wang X Oncol Rep; 2017 Jan; 37(1):465-473. PubMed ID: 27878289 [TBL] [Abstract][Full Text] [Related]
34. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma. Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698 [TBL] [Abstract][Full Text] [Related]
35. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells. Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364 [TBL] [Abstract][Full Text] [Related]
36. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma. Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734 [TBL] [Abstract][Full Text] [Related]
37. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4. Wan J; Liu H; Yang L; Ma L; Liu J; Ming L Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma. Gong SJ; Feng XJ; Song WH; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM Cancer Biol Ther; 2016; 17(2):151-62. PubMed ID: 26618405 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12. Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285 [TBL] [Abstract][Full Text] [Related]
40. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells]. Qin AD; Liu XX; Li J; Liu J; Li YS Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]